In addition, inhibition of other ADAM17 activators for instance ROS, as showed by our group using lipoic acid or a SOD mimetic, tempol, were able to prevent the hypertension development in a DOCA-salt hypertension model (De Queiroz et al., 2015). Here, ADAM17 is linked to Hypertension.